Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF, U.K.
Fluvoxamine 50mg Film-Coated Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White to off-white, film coated circular tablets. Upper face FX/50, lower face CP. |
Fluvoxamine Maleate 50mg.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Fluvoxamine |
The mechanism of action of fluvoxamine is thought to be related to selective serotonin re-uptake inhibition in brain neurones. There is minimum interference with noradrenergic processes. Receptor binding studies have demonstrated that fluvoxamine has negligible binding capacity to alpha adrenergic, beta adrenergic, histaminergic, muscarine cholinergic, dopaminergic or serotonergic receptors. |
| List of Excipients |
|---|
|
Mannitol |
Blister strip consisting of hard tempered aluminium foil (20 micron) and PVC film (250 micron) containing 30, 60 and 90 tablets in cartons.
Not all pack sizes may be marketed.
Wockhardt UK Ltd, Ash Road North, Wrexham, LL13 9UF, U.K.
PL 29831/0096
Date of first authorisation: 18 September 2000
Date of latest renewal: 03 March 2008
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
